Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 6,920 in Johnson and Johnson

  1. BIOLASE Creates Global Commercialization TeamRead the original story

    Monday Aug 25 | Business Wire

    BIOLASE, Inc. , the world's leading manufacturer and distributor of dental lasers, today announced that as part of its ongoing transformation it has created a new Global Commercialization Team and has hired two seasoned executives to lead its worldwide sales and marketing organizations.

    Comment?

  2. Cilag GmbH International Acquires Covagen AGRead the original story w/Photo

    Monday Aug 25 | Pharmaceutical Processing

    Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology platform.

    Comment?

  3. BIOLASE Creates Global Commercialization TeamRead the original story

    Monday Aug 25 | Freshnews

    BIOLASE, Inc. , the world's leading manufacturer and distributor of dental lasers, today announced that as part of its ongoing transformation it has created a new Global Commercialization Team and has hired two seasoned executives to lead its worldwide sales and marketing organizations.

    Comment?

  4. Janssen Pharmaceutical Inc. Affiliate AcquiresRead the original story

    Monday Aug 25 | BioSpace

    The opportunity was identified and facilitated through the Johnson & Johnson Innovation Center in London.

    Comment?

  5. Edmond De Rothschild Investment Partners Sells Its Position In...Read the original story

    Monday Aug 25 | BioSpace

    Edmond De Rothschild Investment Partners Sells Its Position In Covagen To Janssen Affiliate Cilag Gmbh International , A Johnson & Johnson Company Edmond De Rothschild Investment Partners announced today that a BioDiscovery 3 portfolio company, Covagen A.G., has been acquired by Cilag GmbH International, an affiliate of the Janssen Pharmaceutical ... (more)

    Comment?

  6. VIVUS acquires patents from Janssen PharmaceuticalsRead the original story

    Tuesday Aug 12 | Theflyonthewall.com

    VIVUS acquires patents from Janssen Pharmaceuticals VIVUS announced the acquisition of a group of patents from Janssen Pharmaceuticals covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions.

    Comment?

  7. DePuy Pinnacle Lawsuits Move Forward, With Issuance of Proposed Order ...Read the original story w/Photo

    Sunday Aug 24 | PRWeb

    The Firm is representing numerous plaintiffs in Pinnacle hip lawsuits, all of whom allegedly suffered serious injuries due to a metal-on-metal version of the DePuy Pinnacle Hip Replacement System.

    Comment?

  8. Viacyte Partners with Janssen on Diabetes TherapyRead the original story w/Photo

    Saturday Aug 23 | The San Diego Union-Tribune

    San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.

    Comment?

  9. James Surowiecki: Exit Through LobbyRead the original story w/Photo

    Oct 11, 2009 | New Yorker

    Resigning in protest is not in the American grain. Robert McNamara stuck around as Secretary of Defense even after he decided that the Vietnam War was a disaster; Colin Powell did the same during the Bush Administration's push for war with Iraq; and in the lead-up to the financial crisis, few high-profile executives stepped down over disagreements ... (more)

    Comment?

  10. New market study, "McNeil Iberica SLU in Consumer Health (Spain)", has been publishedRead the original story

    Friday Aug 22 | PR-inside.com

    However, during 2013 the company showed a much lower profile in terms of new launches and television campaigns.

    Comment?

  11. Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market TurfRead the original story w/Photo

    Friday Aug 22 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  12. Using antibacterial everything could actually make you sickRead the original story w/Photo

    Friday Aug 22 | World Magazine

    Antibacterial compounds, found in more than 2,000 everyday products, may pose health risks for pregnant women and their unborn babies, scientists reported at the 248th National Meeting & Exposition of the American Chemical Society last week.

    Comment?

  13. Junior Achievement of N.J., which brings real-world financial skills to schools, continues to growRead the original story w/Photo

    Friday Aug 22 | The Jersey Journal

    While sitting in her business and marketing classes in college, Catherine Milone envisioned a career in corporate America - recording analytic data at Microsoft, leading project teams at Johnson & Johnson, or sitting at an executive office desk in Bank of America - a stark contrast to working in a classroom.

    Comment?

  14. World's Largest Pharmaceutical Company Signs Agreement with ViaCyte for a Stem Cell Treatment for Type 1 DiabetesRead the original story

    Friday Aug 22 | Holtville Tribune

    It's been a very good week for San Diego based regenerative medicine company ViaCyte and a potentially pivotal week for people battling type 1 diabetes.

    Comment?

  15. SMS service for pregnant womenRead the original story w/Photo

    Friday Aug 22 | Bizcommunity

    A new cellphone application, MomConnect, allows all pregnant women in the country to sign up for a free SMS service, which provides information and advice on pregnancy, and can be used to notify the Department of Health about poor services at clinics.

    Comment?

  16. Stocks with implied volatility movement; JRJC AznRead the original story

    Tuesday Aug 12 | Theflyonthewall.com

    Potential Pfizer, AstraZeneca deal seen around year-end, Reuters says Investors and analysts see Pfizer making another attempt to acquire AstraZeneca around year-end, even though talks between the two can resume on August 26 per British takeover rules, Reuters reports.

    Comment?

  17. Johnson & Johnson Target of Unusually Large Options TradingRead the original story

    Thursday Aug 21 | AmericanBankingNews.com

    Shares of Johnson & Johnson were the recipient of unusually large options trading on Thursday.

    Comment?

  18. UPDATE 1-FDA approves use of Eliquis to treat leg, lung clotsRead the original story

    Thursday Aug 21 | Reuters

    Bristol-Myers Squibb Co and Pfizer Inc on Thursday said U.S. regulators have approved an expanded use for their Eliquis blood clot preventer, to treat blood clots in the legs and lungs.

    Comment?

  19. ViaCyte gets $20M for diabetes therapy trialsRead the original story

    Thursday Aug 21 | The San Diego Union-Tribune

    Human embryonic stem cells were differentiated into cells of the pancreas . These cells give rise to insulin-producing cells .

    Comment?

  20. Kentucky's first Primrose School opens in LouisvilleRead the original story w/Photo

    Thursday Aug 21 | Business Journal

    ... y. Andy Almond has retained his job in medical-service sales for a division of New Brunswick, N.J.-based Johnson and Johnson Inc. (NYSE: JNJ).

    Comment?